Agency / Source: Bruker Corporation

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Bruker Launches FluoroType® SARS-CoV-2/Flu/RSV PCR Panel in Europe with CE-IVD Mark - Bruker Corporation today announced the launch of the FluoroType SARS-CoV-2/Flu/RSV winter four-plex PCR panel - Hain-Lifescience.de / Bruker.com
Bruker Launches FluoroType® SARS-CoV-2/Flu/RSV PCR Panel in Europe with CE-IVD Mark

 

PRZOOM - /newswire/ - Nehren, Baden-Württemberg, Germany, 2020/12/18 - Bruker Corporation today announced the launch of the FluoroType SARS-CoV-2/Flu/RSV winter four-plex PCR panel - Hain-Lifescience.de / Bruker.com. NASDAQ: BRKR

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Electronics / Instrumentation / RFID Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

• Winter four-plex panel detects clinically most important respiratory viruses SARS-CoV-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV);
• Validation with nasopharyngeal swabs and oropharyngeal swabs for highest sensitivity;
• Saliva sampling option convenient for patients, while also achieving high PCR sensitivity; saliva samples do not require extraction and enable a faster, resource-effective workflow.

Bruker Corporation today announced the launch of the FluoroType SARS-CoV-2/Flu/RSV winter four-plex PCR panel, which enables the sensitive and simultaneous detection of the SARS-CoV-2 virus, of both influenza A and B viruses, as well as of the respiratory syncytial virus (RSV). In the winter season, multiple viruses need to be differentiated in one assay to facilitate diagnosis and patient management.

The FluoroType SARS-CoV-2/Flu/RSV panel is CE-IVD labelled according to European IVD Directive (98/79/EC). It has been validated for nasopharyngeal swabs, oropharyngeal swabs and saliva samples. The kit includes all reagents to generate up to 96 PCR result panels in under two hours after nucleic acid extraction. In evaluations, the sensitivity and specificity from 112 nasopharyngeal or oropharyngeal swabs have achieved 100% for all four viruses with very low limits of detection. In addition, the winter four-plex panel has also been validated with an RNA extraction-free protocol on 60 saliva samples with 100% sensitivity and 97.5% specificity. In large scale patient sampling and diagnostic use, sensitivity and specificity near 100% may not always be achievable, but swab and saliva PCR protocols remain the most sensitive assays.

Saliva samples are convenient for patients, e.g. during repeat surveillance or longitudinal testing. Saliva PCR testing is also resource-effective for clinical laboratories in case of extraction kit shortages, and time-to-result is shortened. For optimal performance from saliva, it is recommended not to eat, drink, brush teeth or rinse prior to sampling.

The FluoroType SARS-CoV-2/Flu/RSV panel can be used with Bruker's high-precision FluoroCycler® XT real-time PCR system, or with other common real-time thermocyclers. It is validated for use on Bruker's GenoXtract® (GXT) automated nucleic acid extraction devices with associated Bruker RNA extraction kits, and for Qiagen extraction chemistry, as well as for the saliva workflow without RNA extraction.

Dr. Steffi Czieschnek, the Head of PCR Diagnostics at the Medical Healthcare Center (MVZ) for Clinical Chemistry and Microbiology in Suhl, Germany, explained: “For many months, Bruker's high-quality FluoroType SARS-CoV-2 plus assay was our standard for COVID-19 testing. For the winter season, with an increased incidence of influenza infections, we also needed differentiation of multiple respiratory viruses in one test to avoid additional workload or costs. In an early access program, we have internally validated the FluoroType SARS-CoV-2/Flu/RSV panel, and we are very pleased with the performance of this winter four-plex panel, which we now use broadly for our respiratory disease samples.”

Dr. Wolfgang Pusch, Executive Vice President Microbiology & Diagnostics at Bruker Daltonics, commented: “We appreciate the positive customer feedback on the performance of our new FluoroType SARS-CoV-2/Flu/RSV panel. Compared to PCR assays that detect only the SARS-CoV-2 virus, our winter four-plex panel offers added value in a cost-effective workflow. Our clinical laboratory customers now also have the option of offering the saliva workflow for patient convenience, faster time-to-result, and reduced resource requirements without RNA extraction.”

About Bruker-Hain Diagnostics

Bruker-Hain Diagnostics (hain-lifescience.de) is focused on Molecular Diagnostics (MDx) products within Bruker's Microbiology & Diagnostics business. Hain Lifescience GmbH is also the manufacturer of the FluoroCycler® XT, MTBDR 2.0 assay, GXT nucleic acid preparation kits and of the FluoroType SARS-CoV-2 plus assays.

About Bruker Corporation

Bruker (bruker.com) is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology.

Investor Contact: Miroslava Minkova - Director of Investor Relations and Corporate Development
T: +1 978-663 3660 x1479 - E: investor.relations[.]bruker.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Electronics / Instrumentation / RFID Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Bruker Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Electronics / Instrumentation / RFID articles,
CATCH Visitors via Your Competitors Announcements!


Bruker Launches FluoroType® SARS-CoV-2/Flu/RSV PCR Panel in Europe with CE-IVD Mark

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
The FluoroType | Bruker Corporation
Contact: Philip Perry - Bruker Daltonics 
+49 172-313-7216 philip.perry[.]bruker.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Bruker Corporation securities in any jurisdiction including any other companies listed or named in this release.

Electronics / Instrumentation / RFID via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From Bruker Corporation / Company Profile


Read Electronics / Instrumentation / RFID Most Recent Related Press Releases:

Imec Demonstrates 18nm Pitch Line/Space Patterning with a High-Chi Directed Self-Assembly Process
SARCURA and Imec to Collaborate on High Throughput Cytometry Solution for Automated (T-)cell Separation
Kontron Introduces New Embedded pITX Motherboard iMX8M
New 10 GbE Switch Module Delivers 10x Performance Increase for Curtiss-Wright’s PacStar® Modular Data Center
Imec Pushes Single-Exposure Patterning Capability of 0.33NA EUVL to its Extreme Limits
Tiempo Secure is A Winner of French Government’s Great Cybersecurity Challenge
Eurotech Commended by Frost and Sullivan for Leveraging A Large Partnership Ecosystem to Facilitate IoT Deployments
Imec Showcases World’s First Sub-5mW, IEEE 802.15.4z Ultra-Wideband Transmitter Chip
Kontron Further Expands its SMARTCASE™ Kit Solutions
Thales and Airbus Selected by DGA to Upgrade France's Joint Electronic Warfare Capabilities

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  iBet.ag







 
  ©2021 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today